Latest News in the pharma Industry
Market News
Piramal Pharma Solutions announces large-scale expansion of API manufacturing facilities
16 Oct 2017
The investments will enable the CDMO to support the commercialisation of its pipeline of more than 80 programs that are at Phase II or beyond.
Read more
CPhI Worldwide report highlights unpredictability in CDMO growth over next 5 years
13 Oct 2017
Future acquisitions will not be dominated by big deals and large mergers, but rather smaller commentary services and niche technologies to fill specific technology asset gaps.
Read more
SGS and Bavarian Nordic to develop a novel and differentiated challenge model for RSV
13 Oct 2017
Project will build upon the results of Phase II trials undertaken by Bavarian Nordic.
Read more.png)
Maximising API performance with high purity excipients
13 Oct 2017
Croda on hand at CPhI to increase API delivery and improve API stability.
Read more
Cambrex invests in generic API development and manufacturing capabilities at its Milan site
12 Oct 2017
Investments include the installation of development and analytical equipment to support the development of highly potent APIs.
Read more
New compact and high-speed powder filling
9 Oct 2017
Output of up to 480 vials per minute and the number of filling points can be individually selected.
Read more
Troubleshooting from a tablet manufacturer’s perspective
9 Oct 2017
I Holland to host a solutions-led seminar focusing on resolving tablet compression issues.
Read more
Rentschler Biotechnologie transitions into a European corporation called Rentschler Biopharma SE
9 Oct 2017
This legal form of company strengthens its position as a full-service CDMO and ensures its place as an industry leader.
Read more_Logo.jpg){kind=logo}
Boosting capabilities through collaboration
8 Oct 2017
CDMO, Micro-Sphere partners with German machine manufacturer Harro Höfliger for the latest step in its 21 million CHF (€19 million) investment into its facility in Switzerland.
Read more.jpg)
Bavarian Nordic secures contract award for supply of freeze-dried Imvamune smallpox vaccine to the US government
4 Oct 2017
Initial base award secures additional Imvamune bulk contract of USD 100 million.
Read more
Merck invests €35 million in its Italian biotech manufacturing site of Bari
4 Oct 2017
New production line for the aseptic filling of biotech medicines under isolator.
Read more
Tubilux selects TraceLink to achieve EU FMD Compliance
3 Oct 2017
By leveraging TraceLink’s network tenant architecture, Tubilux can eliminate the complexity and costs associated with point-to-point integrations for its EU pharmaceutical manufacturing customers.
Read more